After-Hours Movers 02/04: (STX) Higher; (OPK) (HLIT) (GOOGL) (more...)

February 4, 2019 5:28 PM

After-Hours Movers

OPKO Health, Inc. (NASDAQ: OPK) 19% LOWER; announced that, subject to market and other conditions, it intends to offer $200 million aggregate principal amount of Convertible Senior Notes due 2025 in an underwritten public offering. The Notes will be general senior unsecured obligations of the Company, will pay interest semiannually in arrears and will be convertible into, at the Companys election, cash, shares of the Companys common stock, or a combination of cash and common stock, as further described in the prospectus supplement. The Company intends to grant the underwriter an option to purchase up to an additional $30 million aggregate principal amount of the Notes to cover over-allotments, if any.

Harmonic (NASDAQ: HLIT) 13.9% LOWER; reported Q4 EPS of $0.11, $0.06 better than the analyst estimate of $0.05. Revenue for the quarter came in at $113.6 million versus the consensus estimate of $112.95 million

BioLineRx (NASDAQ: BLRX) 11.5% LOWER; commenced an underwritten public offering of American Depositary Shares (ADSs), each representing one of its ordinary shares with each ADS to be sold together in a fixed combination with a warrant to purchase ADSs. All of the securities in the offering are to be sold by BioLineRx. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Glu Mobile (NASDAQ: GLUU) 9.8% LOWER; reported Q4 EPS of ($0.01), $0.08 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $95.6 million versus the consensus estimate of $95.98 million.

Rudolph Technologies (NYSE: RTEC) 8.5% LOWER; reported Q4 EPS of $0.29, $0.02 better than the analyst estimate of $0.27. Revenue for the quarter came in at $62.78 million versus the consensus estimate of $62.54 million. Rudolph Technologies sees Q1 2019 EPS of $0.19-$0.25, versus the consensus of $0.32. Rudolph Technologies sees Q1 2019 revenue of $56-63 million, versus the consensus of $66.14 million.

Control4 (NASDAQ: CTRL) 7.3% LOWER; reported Q4 EPS of $0.44, $0.01 better than the analyst estimate of $0.43. Revenue for the quarter came in at $72.5 million versus the consensus estimate of $73.16 million. Control4 sees Q1 2019 EPS of $0.08-$0.11, versus the consensus of $0.22. Control4 sees Q1 2019 revenue of $61-63 million, versus the consensus of $64.43 million. Control4 sees FY2019 EPS of $1.18-$1.25, versus the consensus of $1.54. Control4 sees FY2019 revenue of $295-301 million, versus the consensus of $300.85 million.

Luminex Corp. (NASDAQ: LMNX) 5.6% LOWER; reported Q4 EPS of $0.04, $0.05 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $81.1 million versus the consensus estimate of $79.43 million. Luminex Corp. sees Q1 2019 revenue of $82-84 million, versus the consensus of $85.3 million. Luminex Corp. sees FY2019 revenue of $337-343 million, versus the consensus of $340.53 million

Legg Mason (NYSE: LM) 5.2% LOWER; reported Q3 EPS of $0.73, ex-items, $0.05 better than the analyst estimate of $0.68. Revenue for the quarter came in at $704.3 million versus the consensus estimate of $724.61 million.

Gilead Sciences (NASDAQ: GILD) 3.8% LOWER; reported Q4 EPS of $1.44, $0.27 worse than the analyst estimate of $1.71. Revenue for the quarter came in at $5.8 billion versus the consensus estimate of $5.49 billion. Gilead Sciences sees FY2019 revenue of $21.3-21.8 billion, versus the consensus of $21.74 billion. Product Gross Margin 85% - 87%

Invesco Mortgage Capital Inc. (NYSE: IVR) 3.1% LOWER; announced today that it plans to make a public offering of 14 million shares of its common stock.

Seagate Technology (NASDAQ: STX) 2.8% HIGHER; reported Q2 EPS of $1.41, $0.13 better than the analyst estimate of $1.28. Revenue for the quarter came in at $2.7 billion versus the consensus estimate of $2.72 billion.

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) 2.6% LOWER; reported Q4 EPS of $12.77, $1.91 better than the analyst estimate of $10.86. Revenue ex-TAC for the quarter came in at $31.84 billion versus the consensus estimate of $31.33 billion. Total fourth quarter revenue grew 22% to $39.276 billion, versus the consensus of $38.98 billion.

Categories

Special Reports

Next Articles